Braze, Inc. (BRZE): what the price requires

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/BRZE

Headline

Field	Value
Ticker	BRZE
Company	Braze, Inc.
Current price	$26.25/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	revenue-multiple
EV / sales paid	3.9x
Steady-state operating margin assumed	26.9%
Must persist for	6.4y

The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.

Solve inputs: computed at a 13.2% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~1.7 years.

Reconcile: at the x-ray's 9.3% required return this reads ~6.4%/yr; the models below use their own rates.

How unusual the bet is: elevated

Reference	Value
vs own history	-1.18σ
sustained it ~6.4 years at this level	26%
implied end-window share	0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	5.28x	2	expensive
Earnings	4.09x	1	expensive
Relative	0.46x	2	justifies
Growth	0.75x	3	justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.

Per-Model Detail (n=8)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$25.95	1.01x	yes	FCF base $0.1B, growth 25% (input: historical growth), terminal g 4.0%, WACC 9.0%, 7yr projection
DCF Exit Multiple	Growth	$0.00	—	no	Negative/zero FCF or EBITDA — equity value floored at $0
Relative Valuation	Relative	$56.83	0.46x	yes	P/S fallback (negative EPS): Sector P/S 8.0x × TTM revenue — excluded from consensus
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$5.25	5.00x	yes	Book value floor: BV/sh $5.25, ROE negative
Two-Stage Excess Return	Asset	$4.72	5.56x	yes	Book value with convergence: BV/sh $5.25, ROE converges to ke
Discounted Future Market Cap	Growth	$35.21	0.75x	yes	Rev $0.8B, growth 27% (input: historical growth; tapered), Terminal P/S: 3.0x / 3.7x / 4.4x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair Value	Relative	$0.00	—	no	Negative/zero EPS — earnings-based value floored at $0
Margin Trajectory	Growth	$52.29	0.50x	yes	Margin ramp: -16% → 22% over 7yr, rev growth 27% (input: historical growth; tapered)
Earnings Power Value	Earnings	—	—	no	—
Residual Income	Asset	—	—	no	—
Graham Number	Asset	—	—	no	—
EV/EBITDA Relative	Relative	—	—	no	—
FCF Yield	Earnings	$6.41	4.09x	yes	FCF $65.9M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF Yield	Earnings	—	—	no	—
Ben Graham Formula	Earnings	—	—	no	—
ROIC-Justified P/B	Asset	—	—	no	—
P/Sales Sector	Relative	$56.83	0.46x	yes	Revenue $0.79B × sector P/S 8.0x
PEG Fair Value	Relative	—	—	no	—
Earnings Yield	Earnings	—	—	no	—
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net cash	$387.5m
Share count CAGR (dilution)	4.4%
Burning cash	no

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

At about $20, Braze trades near 2.6 times revenue, a modest multiple for a company still growing the top line around 30%. Inverted, the price implies the business eventually reaches an operating margin near 27% while growing revenue about 13% a year, an assumption that sits within what comparable software firms have delivered.

The company is not yet GAAP-profitable, and that is the heart of the valuation puzzle. Trailing operating income is negative, but the business already generates positive free cash flow and carries net cash of roughly $388 million with no debt, so the loss is an investment choice rather than a survival problem.

The most recent quarter showed durable growth: revenue up about 30% year over year, dollar-based net retention around 110%, and management raising full-year guidance while guiding to meaningfully higher non-GAAP operating income. The market is pricing the stock well below the sector revenue multiple, which is the gap the bull and bear cases argue over.

Bull Case

What the standard valuation models miss about Braze is the difference between a company that loses money because it cannot make money and one that loses money because it chooses to keep spending to capture a growing market. On the income statement Braze shows a negative operating margin, around negative 17% on a trailing basis, which a naive earnings-based model reads as a failing business. But the cash statement tells a different story: the company already produces positive free cash flow, recently about $27 million in a single quarter, and sits on roughly $388 million of net cash with no debt. The GAAP loss is largely stock compensation and reinvestment in sales and product. The business underneath is funding its own growth and then some.

The product and the customer behavior are what the multiple should be paying for. Braze runs a customer-engagement platform that brands use to send personalized messages across channels, and its value compounds as customers route more of their messaging through it. The 10-K describes how large customers expand usage through team and region management, where "customers can create groups to manage individual regions or subsets of their businesses" (FY2025 10-K, accession 0001676238-25-000054), the kind of land-and-expand dynamic that shows up as dollar-based net retention around 110%. The most recent quarter grew revenue about 30% year over year with 27% organic growth, customer count climbed past 2,700 with 349 accounts spending $500,000 or more in annual recurring revenue, and management raised full-year guidance to roughly 22% growth while guiding non-GAAP operating income up sharply. Growth is decelerating from earlier years but margins are inflecting positive, which is exactly the transition a profitable software compounder makes.

The AI layer is the optionality the static frames cannot price. Braze completed the acquisition of OfferFit, an AI decisioning company, in mid-2025 and has been rolling out agentic AI products, BrazeAI Operator, an Agent Console, and Project Catalyst, that aim to automate personalization and optimization for its customers. If those features deepen usage and pricing power rather than commoditize, the implied 27% terminal operating margin the price requires looks achievable, and at 2.6 times revenue against a sector that trades far higher, the stock is being valued as if the margin transition fails. The bull case is simply that it does not.

Bear Case

The valuation methods disagree sharply on Braze, and the disagreement itself is the warning. The relative and sector revenue-multiple methods land near $57, far above the price, because they apply a generous software price-to-sales multiple to a fast grower. The growth and margin-trajectory methods land in the mid-$20s to low $50s, all of them crediting a successful path to high margins. But the conservative methods, the ones anchored in what the company has actually earned rather than what it might earn, land far lower: the book-value and excess-return reads sit near $5 because returns on equity are negative, and the zero-growth free-cash-flow capitalization lands near $6. When the optimistic methods say $50-plus and the methods grounded in current profitability say $5 to $6, the honest read is that almost the entire value rests on a margin transition that has not happened yet.

That transition is the crux, and it is not guaranteed. Braze still runs a negative operating margin on a trailing basis, and the price requires it to reach roughly 27% terminal operating margin while sustaining low-teens revenue growth for years. The company guides to only modestly positive non-GAAP operating income, and the gap between non-GAAP and GAAP is largely stock-based compensation, which dilutes shareholders even when it does not burn cash. Revenue growth is decelerating, from the high-30s in prior years toward roughly 22% guided for the current year, and dollar-based net retention around 110% is healthy but down from the much higher figures the company posted at its peak. A company whose net retention is drifting toward break-even expansion is a company whose existing customers are adding less incremental spend than they used to.

Competition is the structural pressure on the margin story. Braze sells into a crowded market against large marketing clouds like Adobe and Salesforce that can bundle similar capabilities, and against focused rivals like Iterable, Klaviyo, and Airship that compete on price and verticals. The same AI wave that gives Braze new products also lowers the barrier for competitors and for customers to build in-house, which is why several analysts have been trimming targets to account for AI disruption risk even as the company grows. Add a recent CFO departure to the picture and the execution risk rises at exactly the moment the margin inflection needs steady hands. If growth keeps decelerating or the margin ramp stalls, the conservative methods that say $5 to $6 stop looking pessimistic and start looking prescient.

Valuation

Braze is not yet earning a normal operating profit, so the price is set against its sales rather than its earnings. At about $20 (June 27, 2026) the stock trades near 2.6 times revenue, which inverts into a specific implied bargain: the business eventually earns an operating margin of roughly 27% and grows revenue about 13% a year for the next several years. That blends a 67% gross margin with a mature-software conversion assumption. The near-term growth pace is well within what the company has delivered; the open question is whether the margin ever arrives, since only about half of comparable fast-growers sustained this kind of profile for five years.

The method families spread widely, and the spread maps directly onto the bull-bear divide. The sector revenue-multiple read lands near $57 and the margin-trajectory read near $52, both crediting a full transition to software-like profitability. The growth-DCF reads land in the mid-$20s. The conservative, currently-grounded methods land far below the price: the book-value and excess-return methods near $5 because returns on equity are negative, and a zero-growth free-cash-flow capitalization near $6. The blended read across the applicable methods is roughly $26, above today's price, but that blend leans on the methods that assume the margin ramp succeeds.

The plain conclusion: at 2.6 times revenue the market is pricing Braze conservatively for a 30% grower, well below the sector multiple, which means it is skeptical that the margin transition completes cleanly. The stock works if revenue growth holds in the low-to-mid 20s and operating margin climbs toward the high-20s as guided, in which case the relative and trajectory methods are right and the price is cheap. It does not work if growth decelerates faster or the margin ramp stalls under competitive and stock-compensation pressure, in which case the methods anchored in current profitability, the ones pointing at $5 to $6, are the more honest guide. The net cash and positive free cash flow remove the survival risk, but they do not resolve the central bet on margins.

Catalysts

The most recent print was a beat-and-raise. Fiscal first-quarter 2027 revenue was $211.0 million, up 30.2% year over year with 27% organic growth, dollar-based net retention of about 110%, non-GAAP diluted EPS of $0.10, and free cash flow of $26.8 million. Total customers grew to 2,713, with 349 spending at least $500,000 in annual recurring revenue. Management raised full-year revenue guidance to $895 to $899 million, roughly 22% growth, and guided non-GAAP operating income to $70 to $74 million. (stocktitan, Investing.com)

The AI strategy is the multi-year catalyst and the multi-year risk. Braze completed the acquisition of OfferFit, an AI decisioning company, on June 2, 2025, and is integrating its multi-agent engine into the platform. (Braze) It has since rolled out BrazeAI Operator, an Agent Console, a revamped Creative Studio with Figma and Canva integrations, and Project Catalyst, a native AI agent for personalization. Whether these deepen usage or get commoditized is the question analysts are weighing.

Sentiment is mixed and the leadership picture is shifting. Citi raised its target to $55 and TD Cowen to $47, with Stifel at $45 on a Buy, but the average target has drifted to around $35 as several firms trimmed estimates for AI disruption risk. (Simply Wall St) A CFO departure and a new CIO appointment add execution uncertainty during the margin inflection. The things to watch: whether dollar-based net retention stabilizes or keeps drifting lower, whether non-GAAP operating margin keeps expanding toward the levels the price requires, the revenue contribution and competitive impact of the AI products, and the pace of the $100 million buyback against ongoing stock-based dilution.

Peer Cohorts (Per Segment, With Filing Citations)

Braze (customer engagement platform) (reported)

• HUBS (HubSpot, Inc.)
• (no filing in the citation store)
• FRSH (Freshworks Inc.)
• (no filing in the citation store)
• SAIL (SailPoint, Inc.)
• (no filing in the citation store)
• INTA (Intapp, Inc.)
• (no filing in the citation store)
• TTAN (ServiceTitan, Inc.)
• (no filing in the citation store)
• ALKT (ALKAMI TECHNOLOGY, INC.)
• (no filing in the citation store)
• DT (Dynatrace, Inc.)
• (no filing in the citation store)
• GTLB (GITLAB INC.)
• (no filing in the citation store)

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.